4.6 Article

The Loudness Dependence of Auditory Evoked Potentials (LDAEP) as an Indicator of Serotonergic Dysfunction in Patients with Predominant Schizophrenic Negative Symptoms

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Determination of the loudness dependence of auditory evoked potentials: single-electrode estimation versus dipole source analysis

Florence Hagenmuller et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)

Article Clinical Neurology

Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans

Jessica L. Oliva et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)

Review Clinical Neurology

Evidence-based pharmacotherapy of schizophrenia

Stefan Leucht et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)

Review Psychiatry

Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis

Surendra P. Singh et al.

BRITISH JOURNAL OF PSYCHIATRY (2010)

Article Clinical Neurology

Reliability of intensity dependence of auditory-evoked potentials

T. Hensch et al.

CLINICAL NEUROPHYSIOLOGY (2008)

Article Clinical Neurology

Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials

Georg Juckel et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)

Article Clinical Neurology

Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials

Wolfram Kawohl et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)

Article Clinical Neurology

Comparative source localization of electrically and pressure-stimulated multichannel somatosensory evoked potentials

Wolfram Kawohl et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2007)

Review Psychiatry

Schizophrenia: Measurements of psychopathology

J. P. Lindenmayer et al.

PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)

Review Neurosciences

Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease

C. Winograd-Gurvich et al.

BRAIN RESEARCH BULLETIN (2006)

Article Psychiatry

The NIMH-MATRICS consensus statement on negative symptoms

B Kirkpatrick et al.

SCHIZOPHRENIA BULLETIN (2006)

Review Clinical Neurology

Size of burden of schizophrenia and psychotic disorders

W Rössler et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)

Review Biochemistry & Molecular Biology

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

S Miyamoto et al.

MOLECULAR PSYCHIATRY (2005)

Article Neurosciences

Decreased 5-HT1A receptor binding in amygdala of schizophrenia

F Yasuno et al.

BIOLOGICAL PSYCHIATRY (2004)

Article Psychiatry

Relationship between psychopathology and cognitive functioning in schizophrenia

VP Bozikas et al.

COMPREHENSIVE PSYCHIATRY (2004)

Review Psychiatry

A meta-analysis of the efficacy of second-generation antipsychotics

JM Davis et al.

ARCHIVES OF GENERAL PSYCHIATRY (2003)

Review Psychiatry

A review of MRI findings in schizophrenia

ME Shenton et al.

SCHIZOPHRENIA RESEARCH (2001)

Article Medicine, Research & Experimental

Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography

Y Okubo et al.

LIFE SCIENCES (2000)